Priority setting for high cost medications (HCMs) in public hospitals in Australia: A case study

Health Policy

Volumn 84, Issue 1, 2007, Pages 58-66

  Gallego, Gisselle ^a   Taylor, Susan Joyce ^b   Brien, Jo anne Elizabeth ^b,c,d  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Case study; Decision making; Pharmaceuticals

Indexed keywords

ARTICLE; AUSTRALIA; CASE STUDY; DECISION MAKING; DRUG COST; DRUG EFFICACY; MEDICAL ETHICS; PUBLIC HOSPITAL;

DECISION MAKING; HEALTH PRIORITIES; HOSPITALS, PUBLIC; HUMANS; INTERVIEWS AS TOPIC; NATIONAL HEALTH PROGRAMS; NEW SOUTH WALES; ORGANIZATIONAL CASE STUDIES; PHARMACEUTICAL PREPARATIONS;

EID: 34848851021     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2007.05.008     Document Type: Article

References (34)

1. Organisation for Economic Co-operation and Development. OECD Health Data 2003 Show Health Expenditures at an All-time High. Paris: Organisation for Economic Co-operation and Development (OEDC); 2003.
2. Fijn R., van Epenhuysen L.S., Peijnenburg A.J., Brouwers J.R., and de Jong-van den Berg L.T. Is there a need for critical ethical and philosophical evaluation of hospital Drugs and Therapeutics (D&T) committees?. Pharmacoepidemiology and Drug Safety 11 (2002) 247-252
3. Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2002-2003. AIHW cat. no. HSE 32. Canberra: AIHW (Health Services Series no. 22); 2004.
4. Victorian Therapeutic Advisory Group VicTAG. Hospital price and resource allocation review: good practice model for controlling medicines costs in hospitals. Melbourne: Victorian Therapeutics Advisory Group; 2004.
5. Tan E.L., Day R.O., and Brien J.E. Drug and therapeutics committees-are they fulfilling their potential to improve the quality use of medicines?. International Journal of Pharmaceutical Practice 11 (2003) 175-181
6. Donato R., and Scotton R. The Australian health care system. In: Mooney G., and Scotton R. (Eds). Economics and Australian health policy (1999), Allen & Unwin, St Leonards, NSW 20-39
7. The Society of Hospital Pharmacists of Australia (S.). Moving forward-the funding of medicines in Australia's hospitals (2004), The Society of Hospital Pharmacists of Australia (SHPA), Melbourne p. 24
8. Kaye K., Lu C.Y., and Day R.O. Can we deny patients expensive drugs?. Australian Prescriber 29 (2006) 146-148
9. Gallego G., Melocco T., Taylor S.J., and Brien J.E. Impact of high cost drugs for individual patient use. Journal of Pharmaceutical Practice Research 34 (2004) 100-103
10. Sabet P., Maxwell D.J., and Brien J.E. Evaluation of mycophenolate for unregistered indications. Journal of Pharmaceutical Practice Research 34 (2004) 36-38
11. Gallego G., Melocco T., Taylor S.J., and Brien J.E. Access to high-cost drugs: decision makers' perspectives. Journal of Pharmaceutical Practice Research 35 (2005) 18-20
12. Martin D., Shulman K., Santiago-Sorrell P., and Singer P. Priority-setting and hospital strategic planning: a qualitative case study. Critical Care Medicine 31 (2003) 197-201
13. Daniels N., and Sabin J.E. The ethics of accountability in managed care reform. Health Affairs 17 (1998) 50
14. Yin R.K. Case Study Research Design and Methods (2003), Sage Publications, Thousand Oaks
15. Daniels N., and Sabin J.E. Settings limits fairly: can we learn to share medical resources? (2002), Oxford University Press, Oxford
16. Patton M.Q. Qualitative Research and Evaluation Methods (2002), Sage Publications, Newbury Park
17. Mays N., and Pope C. Qualitative research in health care (1996), BMJ Publishing Group, London
18. Coffey A., and Atkinson P. Making sense of qualitative data: complementary research strategies (1996), Sage Publications, Thousand Oaks
19. Gibson J.L., Martin D.K., and Singer P.A. Priority setting for new technologies in medicine: a transdisciplinary study. BMC Health Services Research 2 (2002) 14
20. Rocker G.M., Cook D.J., Martin D.K., and Singer P.A. Seasonal bed closures in an intensive care unit: a qualitative study. Journal of Critical Care 18 (2003) 25-30
21. Mielke J., Martin D.K., and Singer P.A. Priority setting in a hospital critical care unit: qualitative case study. Critical Care Medicine 31 (2003) 2764-2768
22. Gibson J.L., Martin D.K., and Singer P.A. Setting priorities in health care organizations: criteria, processes, and parameters of success. BMC Health Services Research 4 (2004) 25
23. Daniels N. Accountability for reasonableness. British Medical Journal 321 (2000) 1300-1301
24. Hasman A., and Holm S. Accountability for reasonableness: opening the black box of process. Health Care Analysis 13 (2005) 261-273
25. Martin D.K., Giacomini M., and Singer P.A. Fairness, accountability for reasonableness, and the views of priority setting decision-makers. Health Policy 61 (2002) 279-290
26. Sabin J.E., and Daniels N. Making insurance coverage for new technologies reasonable and accountable. The Journal of American Medical Association 279 (1998) 703-704
27. Ham C., and Robert G. Reasonable rationing: international experience of priority setting in health care (2003), Open University Press, Maidenhead
28. Hope T. Rationing and life-saving treatments: should identifiable patients have higher priority?. Journal of Medical Ethics 27 (2001) 179-185
29. Poirier T., and Gianetti V. Clinical and ethical principles on rationing high-cost drugs. The Annals of Pharmacotherapy 29 (1995) 78-81
30. L de Lemos M. Rationing costly treatment: can it be fair?. Journal of Oncology Pharmaceutical Practice 10 (2004) 141-144
31. Singer P.A. Recent advances: medical ethics. British Medical Journal 321 (2000) 282-285
32. The Pharmaceutical Management Agency (PHARMAC). How should high cost medicines be funded? Public consultation; December 2006.
33. Daniels N., and Sabin J.E. Making pharmacy benefits accountable for reasonableness. Settings limits fairly: can we learn to share medical resources? (2002), Oxford University Press, Oxford p. 105-19
34. Daniels N., Teagarden J.R., and Sabin J.E. An ethical template for pharmacy benefits. Health Affairs 22 (2003) 125-137